S

SanRo Clinical Research Group | Bryant, AR

Research site

(Unclaimed)

Location

3005 Corporate Center Drive, Bryant, Arkansas, United States of America

Site insights

Top conditions

Top treatments

JZP150

LY3502970

SP-624

Orforglipron

SEP-4199

Metformin

Centanafadine

Azetukalner

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 6 total trials

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)

X-NOVA3 is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of...

Enrolling

Major Depressive Disorder

Drug: Azetukalner

Drug: Placebo

Status recently updated

A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder

This is a Phase 2B clinical study evaluating the effectiveness and safety of SP-624 as compared to placebo in the treatment of adults with Major Depr...

Active, not recruiting

Enrolling

Major Depressive Disorder

Drug: SP-624

Drug: Placebo